Is CVS Health Corp (CVS) overvalued? · P/E 16, rev $402.07B
CVS Health Corp (CVS) is a healthcare plans company listed on US.
This page asks whether CVS Health Corp (CVS) looks expensive on cached numbers — not a short thesis.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CVS 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CVS stock page for the full model, not this heading.
Not investment advice.